Viewing Study NCT00935961


Ignite Creation Date: 2025-12-24 @ 11:58 AM
Ignite Modification Date: 2025-12-29 @ 8:32 PM
Study NCT ID: NCT00935961
Status: COMPLETED
Last Update Posted: 2013-08-09
First Post: 2009-07-07
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module